Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease

Journal of Pharmacology and Experimental Therapeutics

Volumn 311, Issue 2, 2004, Pages 677-682

  Minkeviciene, Rimante ^a   Banerjee, Pradeep ^b   Tanila, Heikki ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b FOREST RESEARCH INSTITUTE   (United States)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

AGGRESSION; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; APP GENE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENOTYPE; LEARNING; LOCOMOTION; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PS1 GENE; SOCIAL BEHAVIOR; SWIMMING; TRANSGENIC MOUSE;

AGGRESSION; ALZHEIMER DISEASE; ANIMALS; DOPAMINE AGENTS; HUMANS; MALE; MAZE LEARNING; MEMANTINE; MICE; MICE, TRANSGENIC; SPATIAL BEHAVIOR;

EID: 6344247564     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.071027     Document Type: Article

References (43)

1. Abi-Saab WM, D'Souza DC, Moghaddam B, and Krystal JH (1998) The NMDA antagonist model for schizophrenia: promise and pitfalls. Pharmacopsychiatry 31 (Suppl 2):104-109.
2. Arendt T, Bruckner MK, Gertz HJ, and Marcova L (1998) Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain. Neuroscience 83:991-1002.
3. Barnes CA, Danysz W, and Parsons CG (1996) Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats. Eur J Neurosci 8:565-571.
4. Benvenga MJ and Spaulding TC (1988) Amnesic effect of the novel anticonvulsant MK-801. Pharmacol Biochem Behav 30:205-207.
5. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, Copeland NG, Price DL, and Sisodia SS (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19:939-945.
6. Cain DP, Saucier D, Hall J, Hargreaves EL, and Boon F (1996) Detailed behavioral analysis of water maze acquisition under APV or CNQX: contribution of sensorimotor disturbances to drug-induced acquisition deficits. Behav Neurosci 110:86-102.
7. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT, et al. (1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2:271-276.
8. Fitzjohn SM, Morton BA, Kuenzi F, Rosahl TW, Shearman M, Lewis H, Smith D, Reynolds DS, Davies CH, Collingridge GL, et al. (2001) Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J Neurosci 21:4691-4698.
9. French ED, Ferkany J, Abreu M, and Levenson S (1991) Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine. Neuropharmacology 30:1039-1046.
10. Hargreaves EL and Cain DP (1995) MKSO1-induced hyperactivity: duration of effects in rats. Pharmacol Biochem Behav 51:13-19.
11. Harkany T, Abraham I, Konya C, Nyakas C, Zarandi M, Penke B, and Luiten PG (2000) Mechanisms of beta-amyloid neurotoxicity: perspectives of pharmacotherapy. Rev Neurosci 11:329-382.
12. Hodges H, Sowinski P, Turner JJ, Fletcher A, Fontana DJ, Daniels SE, Henderson C, Eglen RM, Wong EH, Pitsikas N, et al. (1996) Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system. Psychopharmacology (Berl) 125:146-161.
13. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, et al. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4:97-100.
14. Katagiri H, Tanaka K, and Manabe T (2001) Requirement of appropriate glutamate concentrations in the synaptic cleft for hippocampal LTP induction. Eur J Neurosci 14:547-553.
15. Kornhuber J and Quack G (1995) Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man. Neurosci Lett 195:137-139.
16. Kumar-Singh S, Dewachter I, Moechars D, Lubke U, De Jonghe C, Ceuterick C, Checler F, Naidu A, Cordell B, Cras P, et al. (2000) Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol Dis 7:9-22.
17. Liu L, Ikonen S, Heikkinen T, Tapiola T, van Groen T, and Tanila H (2002) The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology and cognitive function in APP and PS1 doubly transgenic mice. Exp Neurol 173:196-204.
18. Lopez OL, Becker JT, Sweet RA, Klunk W, Kaufer DI, Saxton J, Habeych M, and DeKosky ST (2003) Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease. J Neuropsychiatry Clin Neurosci 15:346-353.
19. Masliah E, Alford M, DeTeresa R, Mallory M, and Hansen L (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 40:759-766.
20. Masliah E, Alford M, Mallory M, Rockenstein E, Moechars D, and Van Leuven F (2000) Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice. Exp Neurol 163:381-387.
21. Mayer ML and Westbrook GL (1987) The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol 28:197-276.
22. McAllister KH (1990) Ethological analysis of the effects of MK-801 upon aggressive male mice: similarity to chlordiazepoxide. Pharmacol Biochem Behav 37:101-106.
23. Miguel-Hidalgo JJ, Alvarez XA, Cacabelos R, and Quack G (2002) Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). Brain Res 858:210-221.
24. Morris RG (1989) Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5. J Neurosci 9:3040-3057.
25. Nakagami Y and Oda T (2002) Glutamate exacerbates amyloid beta1-42-induced impairment of long-term potentiation in rat hippocampal slices. Jpn J Pharmacol 88:223-226.
26. Ouimet CC, Baerwald KD, Gandy SE, and Greengard P (1994) Immunocytochemical localization of amyloid precursor protein in rat brain. J Comp Neurol 348:244-260.
27. Parsons CG, Quack G, Bresink I, Baran L, Przegalinski E, Kostowski W, Krzascik P, Hartmann S, and Danysz W (1995) Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology 34:1239-1258.
28. Pitsikas N, Brambilla A, and Borsini F (1993) DAU 6215, a novel 5-HT3 receptor antagonist, improves performance in the aged rat in the Morris water maze task. Neurobiol Aging 14:561-564.
29. Puoliväli J, Wang J, Heikkinen T, Heikkila M, Tapiola T, van Groen T, and Tanila H (2002) Hippocampal Abeta42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice. Neurobiol Dis 9:339-347.
30. Rammes G, Rupprecht R, Ferrari U, Zieglgansberger W, and Parsons CG (2001) The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci Lett 306:81-84.
31. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ; Memantine Study Group (2003) Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 348:1333-1341.
32. Rogawski MA (2000) Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents: toward an understanding of their favorable tolerability. Amino Acids 19:133-149.
33. Stephan A, Laroche S, and Davis S (2001) Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci 21:5703-5714.
34. Sweeney WA, Luedtke J, McDonald MP, and Overmier JB (1997) Intrahippocampal injections of exogenous beta-amyloid induce postdelay errors in an eight-arm radial maze. Neurobiol Learn Mem 68:97-101.
35. Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, and Gergel I (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. J Am Med Assoc 291:317-324.
36. Tsien JZ, Huerta PT, and Tonegawa S (1996) The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87:1327-1338.
37. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, and Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature (Lond) 416:535-539.
38. Wang J, Ikonen S, Gurevicius K, Van Groen T, and Tanila H (2003) Altered auditory-evoked potentials in mice carrying mutated human amyloid precursor protein and presenilin-1 transgenes. Neuroscience 116:511-517.
39. Wenk GL, Zajaczkowski W, Danysz W, and Quack G (1997) Neuroprotection of acetylcholinergic basal forebrain neurons by memantine and neurokinin B infusion of (+)-MK-801 and memantine: contrasting effects on radial maze learning in rats with entorhinal cortex lesion. Behav Brain Res 83:129-133.
40. Wolfer DP, Madani R, Valenti P, and Lipp HP (2001) Extended analysis of path data from mutant mice using the public domain software Wintrack. Physiol Behav 73:745-753.
41. Zajaczkowski W, Frankiewicz T, Parsons CG, and Danysz W (1997) Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP. Neuropharmacology 36:961-971.
42. Zajaczkowski W, Quack G, and Danysz W (1996) Infusion of (+)-MK-801 and memantine: contrasting effects on radial maze learning in rats with entorhinal cortex lesion. Eur J Pharmacol 296:239-246.
43. Zhang F, Eckman C, Younkin S, Hsiao KK, and Iadecola C (1997) Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. J Neurosci 17:7655-7661.